Clinical Trials Browser

Withdrawn × olaratumab × Clear all

NCT03437070 2019-03-18

Trabectedin, Doxorubicin and Olaratumab in Patients With Metastatic or Recurrent Leiomyosarcoma

Phase 1 Withdrawn

Leiomyosarcoma